Sitemap
- Cookie Policy - Cookie Policy
- Terms of Use - Terms of Use
- Email & Phone subscription PDPN
-
My Account
- Disclaimer
-
Science
-
Cutting Edge Science
- Benign Prostate Hyperplasia (BPH)
-
Neurology
-
Cardiovascular
-
Thrombosis
- Unveiling the Timeline: Major Surgery, VTE Events, and Prolonged LMWH Use
- Advancements in Risk Assessment for VTE associated with Cancer & Hospitalization
- Navigating Complexities in Anticoagulation: Insights for Optimal Management
- Physician’s recommendation is a key for patients adherence to VTE treatment.
- In general surgical patients, the risk of VTE continue to exist after discharge
- Thromboprophylaxis in Covid-19 patient by Prof. Carrier. Interactive interview.
- Effective and safe dose of enoxaparin for the treatment of cancer associated thrombosis: Subgroup analyses of RIETECAT
- Current practice in VTE management in medically ill patients
- Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for world thrombosis day
- Association of extended anticoagulation therapy with risk of recurrent VTE and bleeding rates in cancer-associated VTE
- Real-world in-hospital antiplatelet-switching strategy after coronary interventions: The SWITCH study
- Risk-stratified thromboprophylaxis in special patient groups
- Prof Le Gal's session "Thromboprophylaxis in acute medical illness"
-
Dyslipidemia
- Lipid Assessment, Treatment Optimization and Adherence in ASCVD Patients
- Charting New Horizons in Cardiovascular Care: Unveiling Insights from ESC 2023
- Persistence, effectiveness, and impact on quality of life with long-term PCSK9 inhibitor treatment in patients with familial hypercholesterolemia: Results from the SAFEHEART study
- Treatment gaps in lipid management among high- and very high-risk patients in Europe: The SANTORINI study
- Impact of ESC/EAS 2019 dyslipidemia guidelines on LDL-C goal achievement in ACS patients: The ACS EuroPath IV project
- Routine early treatment with PCSK9i
- Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated
- Lp(a) in clinical practice - Risk estimation and how to reduce its associated risk: A European Atherosclerotic Society consensus statement
-
Atherothrombosis
- Post-hoc analysis of the HOST-EXAM extended study assessing the effect of age on antiplatelet monotherapy during chronic maintenance post-PCI
- Ticagrelor versus clopidogrel in myocardial infarction patients with high bleeding riskrisk: A report from the SWEDEHEART registry
- De-escalation strategies in anti-platelet therapy: Understanding when to switch from a potent agent
- Findings from extended study in patients with CAD
- Long-term clopidogrel monotherapy vs prolonged DAPT beyond 12 months after PCI in high-risk patients
- Ticagrelor vs clopidogrel use in high bleeding risk in hospitalized patients with acute coronary syndrome: findings from the CCC–ACS project
- Meta-analysis of 8 studies (N=29,217) on DAPT in elderly CAD patients published 2007-2020.
- Acute coronary syndrome
-
Thrombosis
- Central Nervous System
- Chronic Kidney Disease
- Consumer health
-
Diabetes
- Exploring the Significance of Time in Range (TIR) for Glycemic Management
- The impact of early hypoglycemia
- Unlocking Insights in Diabetes Management during Ramadan
- Harnessing Technology for Better Outcomes in Diabetes Care
- Explore the importance of Time-in-range (TIR) and glycemic variability (GV)
- How Gla-300 has contributed markedly to patient convenience?
- Are new-generation basal insulins truly better insulins?
- Old and new approaches to glycemic management in diabetes
- Effectiveness of structured Ramadan nutrition plan in patients with type 2 diabetes using continuous glucose monitoring
- Expert panel recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with type 2 diabetes
- T1DM is associated with cognitive dysfunction
- Balancing glucose control & hypoglycemia in T2DM & CKD
- Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement
- What is the "less is more" approach for T2D?
- What should we seek in T2D therapy to address unmet patient needs?
- Fasting during Ramadan in T2DM patients
- Commemorating insulin’s revolutionary discovery
- Real world data on insulin treatment trends
- Simultaneous initiation had better glucose control
- Benefits and applications of TIR diabetes care
- Glycemic variability is an issue for DM patients.
- Asian T2DM patients may benefit from PPG control
- T1DM is associated with cognitive dysfunction
-
Thrombosis
- RIETE registry : The world's largest database on patients with VTE
- LMWH : Antithrombotic choice with key features to diverse needs of your patient with active cancer
- Extended Venous thromboembolism treatment in patients with active cancer
- Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
- Venous thromboembolism (VTE) in cancer patients is a major health burden
- Incidence of venous thromboembolism with immune checkpoint inhibitors in a community setting: A single-center retrospective study.
- Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach
- What is Your Choice of Duration of Treatment for VTE Prophylaxis in High-risk Surgical Patients?
- VTE prophylaxis in general surgical patients
- Personalized approach for management of patients receiving anticoagulants for the treatment of cancer-associated thrombosis
- Evidence based recommendations by EHA/ ESC in the management of antithrombotic treatments in thrombocytopenic patients with cancer
-
Vaccines
-
Childhood
- Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China
- Cost-minimization and opportunity cost analysis of fully-liquid hexavalent and meningococcal vaccines in Spain
- Predominant role of Haemophilus influenzae in the association of conjunctivitis, acute otitis media and acute bacterial paranasal sinusitis in children.
- Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in Southeast England, 2019
- Rabies-Related Knowledge, Attitudes, and Practices among Primary School Students in Chonburi Province, Thailand
- Choosing Hexavalent Vaccine, a globally trusted aP vaccine. Offer the safety, e cacy, consistency & reliability of an ap vaccine.
- Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022
- Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations.
- Burden of Respiratory Syncytial Virus Infection During the First Year of Life.
- A time and motion study.
- Rates and risk factors of severe respiratory syncytial virus infection in 2008-2016 compared with 1986-1998
- Maternal Vaccination and Infant Influenza and Pertussis
- Bordetella pertussis is a common pathogen in infants hospitalized for acute lower respiratory tract infection during the winter season
- Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States
- aP vs wP pertussis vaccines
- Economic Assessment of Incorporating the Hexavalent Vaccine as Part of the National Immunization Program of Peru
- Switching from wP to aP pertussis vaccine
- Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP~T vaccination at 2, 4 and 6 months¹
- A time and motion study of the fully-liquid hexavalent vaccine.
- Choose aP vaccines for improved parents' satisfaction
- A randomized open-label trial Of 2-Dose or 3-Dose pre-exposure Rabies Prophylaxis among Thai children
- aP vs wP pertussis vaccines
- Hexavalent Vaccine is an Acellular Pertussis (aP) Vaccine based on highly purified, selected components of Bordetella Pertussis organisms.
-
General
- A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly
- Epidemiology of Invasive Meningococcal Disease Worldwide from 2010-2019: A Literature Review
- The Burden of Invasive Meningococcal Disease in the Netherlands, 2011-2020
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
-
Influenza
- Estimated Health and Economic Impact of Using High-Dose Influenza Vaccine on Respiratory and Circulatory Plus Respiratory Hospitalizations of Older Adults in Australia
- The Association between Influenza Vaccine and Risk of Chronic Kidney Disease/Dialysis in Patients with Hypertension
- Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study.
- Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan
- Influenza Vaccination for Elderly, Vulnerable and High-Risk Subjects: A Narrative Review and Expert Opinion
- Cost-Effectiveness of High-Dose Quadrivalent Influenza Vaccine Versus Standard-Dose Quadrivalent Influenza Vaccine for Older People in a Country with High Influenza Vaccination Rate
- Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
- Global Burden of Influenza Lower Respiratory Tract Infections in Older People from 1990 to 2019
- Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass
- Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
- Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- Cost-Effectiveness of Influenza Vaccination with a High Dose Quadrivalent Vaccine of the Elderly Population in Belgium, Finland, and Portugal
- WHO recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere
- Burden of Influenza in the Elderly: A Narrative Review
- High-Dose Influenza Vaccine Is Associated with Reduced Mortality among Older Adults with Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
- Correlation between Cardiovascular Protection and Influenza Vaccination
- Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics
- High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: Systematic Review and Meta-Analysis Update
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- The impact of influenza vaccination on cardiovascular disease
- Global, Regional and National Estimates of Influenza-Attributable Ischemic Heart Disease Mortality
- A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections
- Influenza circulating viruses, positivity rate and risk factors for influenza associated severe acute respiratory infection during 2018/2019 winter season, Yemen
- How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population
- Influenza Vaccination and Hospitalization Outcomes Among Older Patients With Cardiovascular or Respiratory Diseases
- The impact of influenza vaccination on cardiovascular disease
- High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 years: Can We Do Better? A Systematic Literature Review
- A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
- Influenza Vaccination and Risk of Stroke in Women with Chronic Obstructive Pulmonary Disease: A Nationwide, Population-Based, Propensity-Matched Cohort Study
- Influenza vaccination is cost-effectiveness
- WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2023-2024
- Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Enhanced Passive Safety Surveillance of High-Dose and Standard-Dose Quadrivalent
- In patients with respiratory disease. Flu can have a devastating impact¹, ²
- WHO recommended composition of influenza virus vaccines for use in the 2023 northern hemisphere
- Influenza vaccine in the patients with CVD
- WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2022-2023
- Influenza vaccine in heart failure patients
-
Pregnancy
- Maternal Vaccination: Shaping the Neonatal Response to Pertussis
- Effectiveness of Maternal Influenza Vaccination During Pregnancy against Laboratory-Confirmed Seasonal Influenza among Infants under 6 Months of Age in Ontario, Canada
- Cost-Effectiveness Analysis of Seasonal Influenza Vaccination During Pregnancy: A Systematic Review
- Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis
- Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis
- Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
-
Childhood
-
Events
-
Upcoming Events
- Past Events
-
Pre-Recorded webinar
-
Central Nervous System
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (part 1)
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (Part 2)
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (Part 3)
- Epilepsy webinar series: Episode 4 - Comprehensive series of childhood onset epilepsy (Part 4)
- Epilepsy webinar series: Episode 5 - A Pharmacological series
- Epilepsy webinar series: Episode 6 - A drug-resistant epilepsy series
- Epilepsy webinar series: Episode 7 - A special population series
- Epilepsy webinar series: Episode 8 - A series of standard vs new anti-seizure medications
- Epilepsy webinar series: Episode 9 - A series of epilepsy comorbidities
- Epilepsy webinar series: Episode 10 - A series of interesting case discussion
- Epilepsy webinar series: Episode 11 - Misdiagnosis of epilepsy series
- Epilepsy webinar series: Episode 12 - Medical management of SE: ER to ICU
- Epilepsy webinar series: Episode 13 - Sudden unexpected death in epilepsy: What we should know to provide better informed advice on SUDEP
- Diabetes
-
Central Nervous System
-
Upcoming Events
-
Take a break
-
Diabetes Café Series
- Diabetes café the series: EP.1 espresso - Bitter of premix unmet need
- Diabetes café the Series: EP.2 Cappuccino - RCTs with pragmatic milk foam
- Diabetes café the series: EP.3 caramel macchiato - fascinating taste of soliMix results
- Diabetes café the series: EP.4 Caffe’ Latte -Fresh milk and clinical implication of soliMix trial
- Diabetes café the series: EP.5 Caffe’ Mocha - Hot chocolate with hot cardiovascular outcome
- Diabetes café the series: EP.7 Caffe’ Misto - Simultaneous approach of brew coffee and streamed milk
- Diabetes café the series: EP.8 Green tea latte - Balanced sweet in renal deficiency
- Diabetes café the series: EP.9 Mango passion fruit smoothies - Fruitful data and careful selection for older people
- Diabetes café the series: EP.10 Matcha Affogato - beyond HbA1c, indulging time-in-range concept
-
VacciCast
- Fully Liquid Hexavalent Vaccine
- FAQ Frequently ask questions about influenza vaccination
- Influenza vaccination in diabetes patient
- Combination Vaccine – Values of aP Vaccine
- Best time to vaccinate against influenza
- Sequential Polio vaccine regimen
- Influenza and cardiovascular event
- WHO Global Meningococcal Initiative
- Meningococcal Vaccines
- Combination Vaccine - Benefits in Clinical Practice
- Traveler Vaccine - IDAT Vaccine Recommendations 2023
- IMD - Vaccine and Recommendations
- IMD - Hajj and Umrah
- IMD - Introduction
- Safety Profile
- QIV HD vs QIV SD
- Combination Vaccine – Pertussis Control
-
Diabetes Café Series
-
Cutting Edge Science
-
Patient Support
-
Innovating in Patient Support
-
Atopic Dermatitis
- Consumer Healthcare
-
Rare Disease
- A story of patient living with Late-Onset Pompe Disease (LOPD)
- A story of patient living with Infantile-Onset Pompe Disease (IOPD)
- Expert guidance on managing allergies and asthma during and after COVID-19
- A story of patient living with Mucopolysaccharidosis type 1 (MPS1)
- A story of patient living with atopic dermatitis
- A story of patient living with Gaucher disease
-
Atopic Dermatitis
-
Resource and Tools
-
Resource and Tools
-
Innovating in Patient Support